Innovation in Biologics Production
Bringing Expensive Biologics within Reach
Oncosimis Biotech is a research and clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercialising therapeutic relevant proteins including mAbs, recombinant proteins. Oncosimis Biotech leverages AcceTT® platform to produce high-quality mAb and recombinant proteins from CHO cells and BacSce® platform to produce endotoxin-free recombinant protein and Fab from E .coli in an efficient and cost-effective manner. Oncosimis proprietary technologies have tremendous potential to reduce the production costs of biologic drugs while increasing yield significantly.
About Us
About Oncosimis
About Oncosimis
About Oncosimis
Oncosimis play an impeccable role in the development of biologic drugs at affordable cost. Oncosimis proprietary technologies have tremendous potential to reduce the production costs of biologic drugs while increasing yield significantly.
What we do?
About Oncosimis
About Oncosimis
Oncosimis Biotech dedicated to develop and produce bio-therapeutic proteins using two proprietary technology platforms, AcceTT® and BacSec® which provides a distinctive advantage to manufacture biosimilar at affordable costs.
Who are we?
About Oncosimis
Who are we?
Oncosimis has leveraged a team of world famous experienced research scientists, doctors, and entrepreneurs in the field of drug discovery, towards manufacturing and commercializing bio-therapeutics.